Skip to main content
. 2019 Apr 30;92(18):e2109–e2117. doi: 10.1212/WNL.0000000000006932

Figure 4. Change from baseline in primary and key secondary efficacy assessments.

Figure 4

(A–D) Data are expressed as mean change from baseline ± standard error. Gray lines indicate placebo; blue lines indicate aceneuramic acid extended-release (Ace-ER). GNEM-FAS = GNE myopathy–Functional Activity Scale; LEC = lower extremity composite; UEC = upper extremity composite.